|
1
|
Honda S, Miyagi H, Suzuki H, Minato M,
Haruta M, Kaneko Y, Hatanaka KC, Hiyama E, Kamijo T, Okada T and
Taketomi A: RASSF1A methylation indicates a poor prognosis in
hepatoblastoma patients. Pediatr Surg Int. 29:1147–1152. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kingston JE, Herbert A, Draper GJ and Mann
JR: Association between hepatoblastoma and polyposis coli. Arch Dis
Child. 58:959–962. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ross JA: Hepatoblastoma and birth weight:
Too little, too big, or just right? J Pediatr. 130:516–517.
1997.PubMed/NCBI
|
|
4
|
Mamlok V, Nichols M, Lockhart L and Mamlok
R: Trisomy 18 and hepatoblastoma. Am J Med Genet. 33:125–126. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Herman JG and Baylin SB: Gene silencing in
cancer in association with promoter hypermethylation. N Engl J Med.
349:2042–2054. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Geiman TM and Robertson KD: Chromatin
remodeling, histone modifications, and DNA methylation-how does it
all fit together? J Cell Biochem. 87:117–125. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Reik W and Walter J: Genomic imprinting:
Parental influence on the genome. Nat Rev Genet. 2:21–32. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chow J and Heard E: X inactivation and the
complexities of silencing a sex chromosome. Curr Opin Cell Biol.
21:359–366. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
O'Sullivan E and Goggins M: DNA
methylation analysis in human cancer. Methods Mol Biol.
980:131–156. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Esteller M: Epigenetics in cancer. N Engl
J Med. 358:1148–1159. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kontos CK, Chantzis D, Papadopoulos IN and
Scorilas A: Kallikrein-related peptidase 4 (KLK4) mRNA predicts
short-term relapse in colorectal adenocarcinoma patients. Cancer
Lett. 330:106–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lose F, Srinivasan S, O'Mara T, Marquart
L, Chambers S, Gardiner RA, Aitken JF; Australian Prostate Cancer
BioResource; Spurdle AB, Batra J and Clements JA: Genetic
association of the KLK4 locus with risk of prostate cancer. PloS
One. 7:e445202012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Haas JE, Feusner JH and Finegold MJ: Small
cell undifferentiated histology in hepatoblastoma may be
unfavorable. Cancer. 92:3130–3134. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Johnson MR, Wang KS, Smith JB, Heslin MJ
and Diasio RB: Quantitation of dihydropyrimidine dehydrogenase
expression by real-time reverse transcription polymerase chain
reaction. Anal Biochem. 278:175–184. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Otte JB: Progress in the surgical
treatment of malignant liver tumors in children. Cancer Treat Rev.
36:360–371. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tiao GM, Bobey N, Allen S, Nieves N,
Alonso M, Bucuvalas J, Wells R and Ryckman F: The current
management of hepatoblastoma: A combination of chemotherapy,
conventional resection, and liver transplantation. J Pediatr.
146:204–211. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
von Schweinitz D: Hepatoblastoma: Recent
developments in research and treatment. Semin Pediatr Surg.
21:21–30. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jia D, Dong R, Jing Y, Xu D, Wang Q, Chen
L, Li Q, Huang Y, Zhang Y, Zhang Z, et al: Exome sequencing of
hepatoblastoma reveals novel mutations and cancer genes in the Wnt
pathway and ubiquitin ligase complex. Hepatology. 60:1686–1696.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dong R, Jia D, Xue P, Cui X, Li K, Zheng
S, He X and Dong K: Genome-wide analysis of long noncoding RNA
(lncRNA) expression in hepatoblastoma tissues. PloS One.
9:e855992014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Baylin SB and Ohm JE: Epigenetic gene
silencing in cancer-A mechanism for early oncogenic pathway
addiction? Nat Rev Cancer. 6:107–116. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Harada K, Toyooka S, Maitra A, Maruyama R,
Toyooka KO, Timmons CF, Tomlinson GE, Mastrangelo D, Hay RJ, Minna
JD and Gazdar AF: Aberrant promoter methylation and silencing of
the RASSF1A gene in pediatric tumors and cell lines. Oncogene.
21:4345–4349. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang SQ, Cai B, Liu L, He YY, Yang YX and
Wan XP: Kallikrein 4 overexpression in endometrial carcinoma and
upregulation by estrogen via mitogen-activated protein kinase
signal pathway. Int J Gynecol Cancer. 19:1377–1383. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Klokk TI, Kilander A, Xi ZJ, Waehre H,
Risberg B, Danielsen HE and Saatcioglu F: Kallikrein 4 is a
proliferative factor that is overexpressed in prostate cancer.
Cancer Res. 67:5221–5230. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xi ZJ, Kaern J, Davidson B, Klokk TI,
Risberg B, Tropé C and Saatcioglu F: Kallikrein 4 is associated
with paclitaxel resistance in ovarian cancer. Gynecol Oncol.
94:80–85. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Papachristopoulou G, Avgeris M and
Scorilas A: Expression analysis and study of KLK4 in benign and
malignant breast tumours. Thromb Haemost. 101:381–387.
2009.PubMed/NCBI
|
|
26
|
Mangé A, Desmetz C, Berthes ML, Maudelonde
T and Solassol J: Specific increase of human kallikrein 4 mRNA and
protein levels in breast cancer stromal cells. Biochem Biophys Res
Commun. 375:107–112. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Doi A, Park IH, Wen B, Murakami P, Aryee
MJ, Irizarry R, Herb B, Ladd-Acosta C, Rho J, Loewer S, et al:
Differential methylation of tissue-and cancer-specific CpG island
shores distinguishes human induced pluripotent stem cells,
embryonic stem cells and fibroblasts. Nat Genet. 41:1350–1353.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Irizarry RA, Ladd-Acosta C, Wen B, Wu Z,
Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, et al:
The human colon cancer methylome shows similar hypo- and
hypermethylation at conserved tissue-specific CpG island shores.
Nat Genet. 41:178–186. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ogoshi K, Hashimoto SI, Nakatani Y, Qu W,
Oshima K, Tokunaga K, Sugano S, Hattori M, Morishita S and
Matsushima K: Genome-wide profiling of DNA methylation in human
cancer cells. Genomics. 98:280–287. 2011. View Article : Google Scholar : PubMed/NCBI
|
